MPWM Advisory Solutions’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

MPWM Advisory Solutions’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.28K	Hold	10	–	–	﹤0.01%	526
2025 Q4	$1.22K	Hold	10	–	–	﹤0.01%	500
2025 Q3	$1K	Hold	10	–	–	﹤0.01%	483
2025 Q2	$829	Hold	10	–	–	﹤0.01%	492
2025 Q1	$811	Hold	10	–	–	﹤0.01%	560
2024 Q4	$901	Buy	+10	New	+$969	﹤0.01%	556

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MPWM Advisory Solutions's XBI Position: Q1 2026 in Review

MPWM Advisory Solutions held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 10 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

MPWM Advisory Solutions first reported a position in XBI in Q4 2024 and has held it in 6 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

MPWM Advisory Solutions held 10 shares of State Street SPDR S&P Biotech ETF worth $1.28K as of Q1 2026.
MPWM Advisory Solutions left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of MPWM Advisory Solutions's portfolio in Q1 2026, its #526 holding.
MPWM Advisory Solutions first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 6 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on MPWM Advisory Solutions's 13F filing for Q1 2026, filed 13 May 2026.